All Work

Chris Lange

More Bright Skies Ahead for Ciena

Ciena reacted very favorably to earnings this week, as it turns out that analysts and investors seem like they just can't get enough of Ciena, based on the upgrades and target hikes that were…

Chris Lange · 8 years ago

Friday’s Biggest Winners and Losers in the S&P 500

Friday was a flat day for the broad U.S. markets, with low volume as everyone is getting ready for the long holiday weekend. Crude oil backed off a little in the session to just…

Chris Lange · 8 years ago

What Tripped Up Ambarella’s Q2

Amarella shares retreated after it released its fiscal second quarter financial results after the markets closed on Thursday.

Chris Lange · 8 years ago

Thursday’s Biggest Winners and Losers in the S&P 500

Thursday was a down day for the broad U.S. markets, cutting off the streak of all-time highs that the S&P 500 and Nasdaq were hitting. Crude oil gained momentum ultimately ending the session on…

Chris Lange · 8 years ago

Sutro Biopharma Gears Up for IPO

Clinical-stage drug maker Sutro Biopharma has filed with the SEC regarding its initial public offering.

Chris Lange · 8 years ago

Should Elon Musk Face Even More Scrutiny?

In the past, Elon Musk has been recognized in his eccentricities and Tesla’s stock has been moved solely on his tweets, but this month has been nothing short of a circus.

Chris Lange · 8 years ago

Elanco Closes in on IPO

Eli Lilly spin-off Elanco Animal Health has amended its filing with the SEC regarding its initial public offering.

Chris Lange · 8 years ago